(Q46110515)

English

Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial

scientific article published in December 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/18665787

Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/18665787

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Stuart L Silverman

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/18665787

Claus Christiansen

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/18665787

Harry K Genant

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/18665787

Slobodan Vukicevic

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/18665787

José R Zanchetta

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/18665787

Tobie J de Villiers

6

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/18665787

Ginger D Constantine

7

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/18665787

Arkadi A Chines

8

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/18665787

publication date

1 December 2008

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/18665787

Journal of Bone and Mineral Research

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/18665787

23

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/18665787

12

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/18665787

1923-1934

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/18665787

The global perspective of osteoporosis : the ILAR lecture, June 2004, Berlin

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

World-wide projections for hip fracture

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Late Physical and Functional Effects of Osteoporotic Fracture in Women: The Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Mortality following fractures in older women. The study of osteoporotic fractures

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis 1

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Estrogen deficiency and bone loss: an inflammatory tale

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Osteoporosis prevention and therapy: preserving and building strength through bone quality

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Bone density and markers of bone turnover in predicting fracture risk and how changes in these measures predict fracture risk reduction

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Relationship of bone turnover to bone density and fractures

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

The revision of the Declaration of Helsinki: past, present and future

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Risk of Mortality Following Clinical Fractures

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.080710

21 January 2018

Identifiers

10.1359/JBMR.080710

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/18665787

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/18665787

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46110515&oldid=2093221703"